278 related articles for article (PubMed ID: 30450096)
1. Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells.
Hellmann I; Waldmeier L; Bannwarth-Escher MC; Maslova K; Wolter FI; Grawunder U; Beerli RR
Front Immunol; 2018; 9():2490. PubMed ID: 30450096
[TBL] [Abstract][Full Text] [Related]
2. Transpo-mAb display: Transposition-mediated B cell display and functional screening of full-length IgG antibody libraries.
Waldmeier L; Hellmann I; Gutknecht CK; Wolter FI; Cook SC; Reddy ST; Grawunder U; Beerli RR
MAbs; 2016; 8(4):726-40. PubMed ID: 26986818
[TBL] [Abstract][Full Text] [Related]
3. Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications.
Goydel RS; Weber J; Peng H; Qi J; Soden J; Freeth J; Park H; Rader C
J Biol Chem; 2020 May; 295(18):5995-6006. PubMed ID: 32193207
[TBL] [Abstract][Full Text] [Related]
4. Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.
Kuo WY; Hsu HJ; Wu CY; Chen HS; Chou YC; Tsou YL; Peng HP; Jian JW; Yu CM; Chiu YK; Chen IC; Tung CP; Hsiao M; Lin CL; Wang YA; Wang AH; Yang AS
MAbs; 2019 Jan; 11(1):153-165. PubMed ID: 30365359
[TBL] [Abstract][Full Text] [Related]
5. Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility.
Peng H; Nerreter T; Chang J; Qi J; Li X; Karunadharma P; Martinez GJ; Fallahi M; Soden J; Freeth J; Beerli RR; Grawunder U; Hudecek M; Rader C
J Mol Biol; 2017 Sep; 429(19):2954-2973. PubMed ID: 28818634
[TBL] [Abstract][Full Text] [Related]
6. High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies.
Ha KD; Bidlingmaier SM; Zhang Y; Su Y; Liu B
Mol Cell Proteomics; 2014 Dec; 13(12):3320-31. PubMed ID: 25149096
[TBL] [Abstract][Full Text] [Related]
7. Retrocyte Display® technology: generation and screening of a high diversity cellular antibody library.
Breous-Nystrom E; Schultze K; Meier M; Flueck L; Holzer C; Boll M; Seibert V; Schuster A; Blanusa M; Schaefer V; Grawunder U; Martin-Parras L; van Dijk MA
Methods; 2014 Jan; 65(1):57-67. PubMed ID: 24036249
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.
Tong XM; Feng L; Suthe SR; Weng TH; Hu CY; Liu YZ; Wu ZG; Wang MH; Yao HP
J Immunother Cancer; 2019 Sep; 7(1):250. PubMed ID: 31519211
[TBL] [Abstract][Full Text] [Related]
9. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
Beerli RR; Hell T; Merkel AS; Grawunder U
PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
[TBL] [Abstract][Full Text] [Related]
10. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
[TBL] [Abstract][Full Text] [Related]
11. Repertoire diversification in mice with an IgH-locus-targeted transgene for the rearranged VH domain of a physiologically selected anti-ssDNA antibody.
Li J; Geissal ED; Li W; Stollar BD
Mol Immunol; 2005 Aug; 42(12):1475-84. PubMed ID: 15950740
[TBL] [Abstract][Full Text] [Related]
12. Mammalian cell display and somatic hypermutation in vitro for human antibody discovery.
King DJ; Bowers PM; Kehry MR; Horlick RA
Curr Drug Discov Technol; 2014 Mar; 11(1):56-64. PubMed ID: 23978037
[TBL] [Abstract][Full Text] [Related]
13. Antibody repertoire analysis of mouse immunization protocols using microfluidics and molecular genomics.
Asensio MA; Lim YW; Wayham N; Stadtmiller K; Edgar RC; Leong J; Leong R; Mizrahi RA; Adams MS; Simons JF; Spindler MJ; Johnson DS; Adler AS
MAbs; 2019 Jul; 11(5):870-883. PubMed ID: 30898066
[TBL] [Abstract][Full Text] [Related]
14. Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
Clarke SC; Ma B; Trinklein ND; Schellenberger U; Osborn MJ; Ouisse LH; Boudreau A; Davison LM; Harris KE; Ugamraj HS; Balasubramani A; Dang KH; Jorgensen B; Ogana HAN; Pham DT; Pratap PP; Sankaran P; Anegon I; van Schooten WC; Brüggemann M; Buelow R; Force Aldred S
Front Immunol; 2018; 9():3037. PubMed ID: 30666250
[TBL] [Abstract][Full Text] [Related]
15. High affinity humanized antibodies without making hybridomas; immunization paired with mammalian cell display and in vitro somatic hypermutation.
McConnell AD; Do M; Neben TY; Spasojevic V; MacLaren J; Chen AP; Altobell L; Macomber JL; Berkebile AD; Horlick RA; Bowers PM; King DJ
PLoS One; 2012; 7(11):e49458. PubMed ID: 23166676
[TBL] [Abstract][Full Text] [Related]
16. A platform-agnostic, function first-based antibody discovery strategy using plasmid-free mammalian expression of antibodies.
Zhang R; Prabakaran P; Yu X; Mackness BC; Boudanova E; Hopke J; Sancho J; Saleh J; Cho H; Zhang N; Simonds-Mannes H; Stimple SD; Hoffmann D; Park A; Chowdhury PS; Rao SP
MAbs; 2021; 13(1):1904546. PubMed ID: 33899674
[TBL] [Abstract][Full Text] [Related]
17. Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity.
Loo D; Alderson RF; Chen FZ; Huang L; Zhang W; Gorlatov S; Burke S; Ciccarone V; Li H; Yang Y; Son T; Chen Y; Easton AN; Li JC; Rillema JR; Licea M; Fieger C; Liang TW; Mather JP; Koenig S; Stewart SJ; Johnson S; Bonvini E; Moore PA
Clin Cancer Res; 2012 Jul; 18(14):3834-45. PubMed ID: 22615450
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-Drug Conjugate for Treatment of CLDN18.2-Positive Cancers.
O'Brien NA; McDermott MSJ; Zhang J; Gong KW; Lu M; Hoffstrom B; Luo T; Ayala R; Chau K; Liang M; Madrid AM; Donahue TR; Glaspy JA; Presta L; Slamon DJ
Mol Cancer Ther; 2023 Dec; 22(12):1365-1375. PubMed ID: 37788341
[TBL] [Abstract][Full Text] [Related]
19. Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates.
Catcott KC; McShea MA; Bialucha CU; Miller KL; Hicks SW; Saxena P; Gesner TG; Woldegiorgis M; Lewis ME; Bai C; Fleming MS; Ettenberg SA; Erickson HK; Yoder NC
MAbs; 2016; 8(3):513-23. PubMed ID: 26752675
[TBL] [Abstract][Full Text] [Related]
20. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
Munekage E; Serada S; Tsujii S; Yokota K; Kiuchi K; Tominaga K; Fujimoto M; Kanda M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
Neoplasia; 2021 Sep; 23(9):939-950. PubMed ID: 34332450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
